TUMORGENESIS

LIVE

Serial Number

88423530

Owner

Precision Therapeutics, Inc.

Attorney

Michael A. Geller

Filing Date

May 9, 2019

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

TUMORGENESIS Trademark

Serial Number: 88423530 • Registration: 6176895

TUMORGENESIS is a trademark filed by Precision Therapeutics, Inc. on May 9, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

Precision Therapeutics, Inc. (41 trademarks)

3636 Boulevard of the Allies
Pittsburgh, PA 15213

Entity Type: 03

PREDICTIVE ONCOLOGY INC. (18 trademarks)

2915 Commers Drive, Suite 900
Eagan, MN 55121

Entity Type: 03

Legal Representation

Attorney of Record

Michael A. Geller

2,539 trademarks filed View all →

Correspondence Address

Michael A. Geller DLA Piper LLP (US)

P.O Box 64807

Chicago, IL 60664-0807

United States

Trademark Details

Filing Date

May 9, 2019

Registration Date

October 13, 2020

First Use in Commerce

June 11, 2020

Goods & Services

Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations, namely, theranostics, therapeutics and immunotherapy drugs for use in the treatment of cancer

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Oct 13, 2025 REM1

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

Jan 2, 2024 EWAF

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Jan 2, 2024 TCCA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Jan 2, 2024 ARAA

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Jan 2, 2024 REAP

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Jan 2, 2024 CHAN

TEAS CHANGE OF OWNER ADDRESS RECEIVED

Jan 2, 2024 COAR

REGISTERED-SUPPLEMENTAL REGISTER

Oct 13, 2020 R.SR

LAW OFFICE PUBLICATION REVIEW COMPLETED

Sep 9, 2020 PREV

ASSIGNED TO LIE

Sep 2, 2020 ALIE

NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED

Aug 28, 2020 AAUA

APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

Aug 27, 2020 CNTA

USE AMENDMENT ACCEPTED

Aug 27, 2020 IUAA

TEAS/EMAIL CORRESPONDENCE ENTERED

Aug 15, 2020 TEME

AMENDMENT TO USE PROCESSING COMPLETE

Aug 15, 2020 AUPC

USE AMENDMENT FILED

Aug 15, 2020 IUAF

CORRESPONDENCE RECEIVED IN LAW OFFICE

Aug 14, 2020 CRFA

TEAS REQUEST FOR RECONSIDERATION RECEIVED

Aug 14, 2020 ERFR

TEAS AMENDMENT OF USE RECEIVED

Aug 14, 2020 EAAU

NOTIFICATION OF FINAL REFUSAL EMAILED

Feb 14, 2020 GNFN

FINAL REFUSAL E-MAILED

Feb 14, 2020 GNFR

FINAL REFUSAL WRITTEN

Feb 14, 2020 CNFR

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

Feb 12, 2020 ASGN

TEAS/EMAIL CORRESPONDENCE ENTERED

Jan 30, 2020 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jan 29, 2020 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jan 29, 2020 TROA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jul 29, 2019 GNRN

NON-FINAL ACTION E-MAILED

Jul 29, 2019 GNRT

NON-FINAL ACTION WRITTEN

Jul 29, 2019 CNRT

ASSIGNED TO EXAMINER

Jul 24, 2019 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

May 24, 2019 NWOS

NEW APPLICATION ENTERED

May 13, 2019 NWAP

Related Trademarks

More from this Owner

PEDAL

SOLUBLE BIOTECH A PREDICTIVE ONCOLOGY COMPANY

More in Same Class

TIMOLOL / LATANOPROST OPHTHALMIC SOLUTION 0.5% / 0.005% OMNI BY OSRX

PREDNISOLONE PHOSPHATE / KETOROLAC TROMETHAMINE OPHTHALMIC SOLUTION 1% / 0.5% OMNI BY OSRX

KYLIE BABY BY KYLIE JENNER

DEXAMETHASONE PO4 / MOXIFLOXACIN HCL 0.1% / 0.5% (SINGLE USE) OMNI BY OSRX

Serial #88423379

FLOSSY